Keyword: Evotec

News

Evotec Enters Multiple Drug Discovery Pacts

26.08.2020 -

German drug discovery and development company Evotec has struck four separate partnership agreements during August.

News

Evotec Links with Leon-Nanodrugs

29.04.2020 -

Evotec has formed a strategic partnership with Leon-Nanodrugs, a German-based provider of nanotechnology for the pharmaceutical industry. 

News

CEVEC and Evox Therapeutics in Exosome Development Pact

17.04.2020 - Germany’s CEVEC Pharmaceuticals and the UK’s Evox Therapeutics have signed a license agreement covering development and commercialization of therapeutic exosomes using CEVEC’s...

News

Evotec Opens Gene Therapy R&D Site in Austria

14.04.2020 - German drug discovery and technology company Evotec has established a dedicated site in Orth/Donau, Austria, for the research and development of gene therapy-based projects. The...

News

Merck KGaA Grants CRISPR License to Evotec

13.11.2019 - Germany’s Merck has signed a license agreement with Evotec, granting the Hamburg-based internationally active biotechnology group access to its CRISPR genome-editing technology...

News

Evotec and Takeda in Drug Discovery Pact

26.09.2019 - German drug discovery and development company Evotec has entered into a strategic, multi-year collaboration with Japan’s Takeda Pharmaceutical that could be worth in excess of $850...

News

Evotec Pays $90 Million for Just Biotherapeutics

27.05.2019 - German drug discovery and development company Evotec has signed an agreement to buy Just Biotherapeutics, a US biologics company. Founded in 2014, Just Biotherapeutics is backed by...

News

Evotec and Sanofi to Link on Infectious Diseases

15.03.2018 - Hamburg, Germany-based drug development specialist Evotec and French drugmaker Sanofi have entered into exclusive negotiations calling for Evotec to accelerate infectious disease...